Distribution And Supply Agreement Sample Contracts

Osmotica Pharmaceuticals Ltd – THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF a CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. AMENDMENT NO. 2 to DISTRIBUTION AND SUPPLY AGREEMENT Between CIPHER PHARMACEUTICALS INC. And VERTICAL PHARMACEUTICALS, INC. (September 14th, 2018)

This Amendment No. 2 to Distribution and Supply Agreement (this Amendment) is entered into as of November 21, 2013 (the Effective Date) by and between Cipher Pharmaceuticals Inc. (Cipher), an Ontario corporation located at 5650 Tomken Road Unit 16, Mississauga Ontario IAW 4Pl, and Vertical Pharmaceuticals, Inc. (Distributor), a corporation organized under the laws of the state of New Jersey with an address at 2500 Main Street Extension, Suite 6, Sayreville, New Jersey 08872. Unless otherwise defined herein, all capitalized terms shall have the meaning specified in the Agreement.

Osmotica Pharmaceuticals Ltd – Distribution and Supply Agreement (September 14th, 2018)

This Distribution and Supply Agreement (the Agreement) is entered into as of June 28, 2011 (the Effective Date) by and between Cipher Pharmaceuticals Inc. (Cipher), an Ontario corporation located at 5650 Tomken Road Unit 16, Mississauga Ontario L4W 4P1, and Vertical Pharmaceuticals Inc. (Distributor), a corporation organized under the laws of the state of New Jersey with an address at 2400 Main Street, Suite 6, Sayreville, New Jersey 08872. Unless otherwise specified, all capitalized terms shall have the meaning specified in Article 1 herein.

Osmotica Pharmaceuticals Ltd – THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF a CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. AMENDMENT NO. 3 to DISTRIBUTION AND SUPPLY AGREEMENT Between (September 14th, 2018)

This Amendment No. 3 (the Third Amendment) to the Distribution and Supply Agreement (the Agreement) is entered into as of the 1st day of January, 2015 (the Effective Date) by and between Cipher Pharmaceuticals, Inc. (Cipher), an Ontario corporation located at 5650 Tomken Road, Unit 16, Mississauga Ontario 14W 4P1, Canada, and Vertical Pharmaceuticals, LLC, as successor to Vertical Pharmaceuticals, Inc. (Distributor), a Delaware limited liability company with an address at 2500 Main Street Extension, Suite 6, Sayreville, New Jersey 08872, each individually a Party and together the Parties.. Unless otherwise defined herein, all capitalized terms shall have the meaning specified in the Agreement.

Osmotica Pharmaceuticals Ltd – AMENDMENT NO. 1 to DISTRIBUTION AND SUPPLY AGREEMENT Between CIPHER PHARMACEUTICALS INC. And VERTICAL PHARMACEUTICALS, INC. (September 14th, 2018)

This Amendment No. 1 to Distribution and Supply Agreement (this Amendment) is entered into as of March 27th, 2012 (the Effective Date) by and between Cipher Pharmaceuticals Inc. (Cipher), an Ontario corporation located at 5650 Tomken Road Unit 16, Mississauga Ontario L4W 411, and Vertical Pharmaceuticals, Inc. (Distributor), a corporation organized under the laws of the state of New Jersey with an address at 2400 Main Street, Suite 6, Sayreville, New jersey 08872. Unless otherwise defined herein, all capitalized terms shall have the meaning specified in the Agreement.

Osmotica Pharmaceuticals Ltd – THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF a CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. AMENDMENT NO. 3 to DISTRIBUTION AND SUPPLY AGREEMENT Between (August 22nd, 2018)

This Amendment No. 3 (the Third Amendment) to the Distribution and Supply Agreement (the Agreement) is entered into as of the 1st day of January, 2015 (the Effective Date) by and between Cipher Pharmaceuticals, Inc. (Cipher), an Ontario corporation located at 5650 Tomken Road, Unit 16, Mississauga Ontario 14W 4P1, Canada, and Vertical Pharmaceuticals, LLC, as successor to Vertical Pharmaceuticals, Inc. (Distributor), a Delaware limited liability company with an address at 2500 Main Street Extension, Suite 6, Sayreville, New Jersey 08872, each individually a Party and together the Parties.. Unless otherwise defined herein, all capitalized terms shall have the meaning specified in the Agreement.

Osmotica Pharmaceuticals Ltd – Distribution and Supply Agreement (August 22nd, 2018)

This Distribution and Supply Agreement (the Agreement) is entered into as of June 28, 2011 (the Effective Date) by and between Cipher Pharmaceuticals Inc. (Cipher), an Ontario corporation located at 5650 Tomken Road Unit 16, Mississauga Ontario L4W 4P1, and Vertical Pharmaceuticals Inc. (Distributor), a corporation organized under the laws of the state of New Jersey with an address at 2400 Main Street, Suite 6, Sayreville, New Jersey 08872. Unless otherwise specified, all capitalized terms shall have the meaning specified in Article 1 herein.

Tesoro Logistics Lp Common Unit – Amendment No. 1 to Fuel Distribution and Supply Agreement (August 7th, 2018)

This AMENDMENT NO. 1 TO FUEL DISTRIBUTION AND SUPPLY AGREEMENT, dated as of the 29th day of June, 2018 (this "Amendment"), is by and between (a) Western Refining Wholesale, LLC, a Delaware limited liability company ("Seller"), and (b) Western Refining Southwest, Inc., an Arizona corporation ("WRSW", and collectively with all of its divisions, subsidiaries or affiliates, other than Andeavor Logistics LP and its subsidiaries, "Purchaser"). Seller and Purchaser are each referred to herein as a "Party" and collectively referred to herein as the "Parties".

Distribution and Supply Agreement (August 3rd, 2018)

This Distribution and Supply Agreement (this "Agreement") is made as of December 20, 2017 (the "Effective Date"), by and between AMAG Pharmaceuticals, Inc., a Delaware corporation with offices located at 1100 Winter Street, Waltham, Massachusetts 02451 (hereinafter referred to as "Manufacturer" and "AMAG"), and Prasco, LLC, a Ohio limited liability company with offices located at 6125 Commerce Court, Mason, Ohio 45040 (hereinafter referred to as "Distributor" and "Prasco") and is to be effective as of the Effective Date. Manufacturer and Distributor are each referred to herein as a "Party" and, collectively, as the "Parties."

Osmotica Pharmaceuticals Ltd – Distribution and Supply Agreement (July 13th, 2018)

This Distribution and Supply Agreement (the Agreement) is entered into as of June 28, 2011 (the Effective Date) by and between Cipher Pharmaceuticals Inc. (Cipher), an Ontario corporation located at 5650 Tomken Road Unit 16, Mississauga Ontario L4W 4P1, and Vertical Pharmaceuticals Inc. (Distributor), a corporation organized under the laws of the state of New Jersey with an address at 2400 Main Street, Suite 6, Sayreville, New Jersey 08872. Unless otherwise specified, all capitalized terms shall have the meaning specified in Article 1 herein.

Osmotica Pharmaceuticals Ltd – AMENDMENT NO. 1 to DISTRIBUTION AND SUPPLY AGREEMENT Between CIPHER PHARMACEUTICALS INC. And VERTICAL PHARMACEUTICALS, INC. (May 9th, 2018)

This Amendment No. 1 to Distribution and Supply Agreement (this Amendment) is entered into as of March 27th, 2012 (the Effective Date) by and between Cipher Pharmaceuticals Inc. (Cipher), an Ontario corporation located at 5650 Tomken Road Unit 16, Mississauga Ontario L4W 411, and Vertical Pharmaceuticals, Inc. (Distributor), a corporation organized under the laws of the state of New Jersey with an address at 2400 Main Street, Suite 6, Sayreville, New jersey 08872. Unless otherwise defined herein, all capitalized terms shall have the meaning specified in the Agreement.

Osmotica Pharmaceuticals Ltd – THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF a CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. AMENDMENT NO. 3 to DISTRIBUTION AND SUPPLY AGREEMENT Between (May 9th, 2018)

This Amendment No. 3 (the Third Amendment) to the Distribution and Supply Agreement (the Agreement) is entered into as of the 1st day of January, 2015 (the Effective Date) by and between Cipher Pharmaceuticals, Inc. (Cipher), an Ontario corporation located at 5650 Tomken Road, Unit 16, Mississauga Ontario 14W 4P1, Canada, and Vertical Pharmaceuticals, LLC, as successor to Vertical Pharmaceuticals, Inc. (Distributor), a Delaware limited liability company with an address at 2500 Main Street Extension, Suite 6, Sayreville, New Jersey 08872, each individually a Party and together the Parties.. Unless otherwise defined herein, all capitalized terms shall have the meaning specified in the Agreement.

Osmotica Pharmaceuticals Ltd – Distribution and Supply Agreement (May 9th, 2018)

This Distribution and Supply Agreement (the Agreement) is entered into as of June 28, 2011 (the Effective Date) by and between Cipher Pharmaceuticals Inc. (Cipher), an Ontario corporation located at 5650 Tomken Road Unit 16, Mississauga Ontario L4W 4P1, and Vertical Pharmaceuticals Inc. (Distributor), a corporation organized under the laws of the state of New Jersey with an address at 2400 Main Street, Suite 6, Sayreville, New Jersey 08872. Unless otherwise specified, all capitalized terms shall have the meaning specified in Article 1 herein.

Osmotica Pharmaceuticals Ltd – THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF a CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. AMENDMENT NO. 2 to DISTRIBUTION AND SUPPLY AGREEMENT Between CIPHER PHARMACEUTICALS INC. And VERTICAL PHARMACEUTICALS, INC. (May 9th, 2018)

This Amendment No. 2 to Distribution and Supply Agreement (this Amendment) is entered into as of November 21, 2013 (the Effective Date) by and between Cipher Pharmaceuticals Inc. (Cipher), an Ontario corporation located at 5650 Tomken Road Unit 16, Mississauga Ontario IAW 4Pl, and Vertical Pharmaceuticals, Inc. (Distributor), a corporation organized under the laws of the state of New Jersey with an address at 2500 Main Street Extension, Suite 6, Sayreville, New Jersey 08872. Unless otherwise defined herein, all capitalized terms shall have the meaning specified in the Agreement.

Heska Corporation – Master Distribution and Supply Agreement (March 9th, 2018)

This Master Distribution and Supply Agreement (this "Agreement") is entered into as of October 17, 2014 (the "Effective Date") by and between Heska Corporation, a Delaware corporation ("Heska") and Butler Animal Health Supply, LLC d/b/a Henry Schein Animal Health, a Delaware limited liability company ("HSAH"). HSAH and Heska are each a "Party" and jointly are the "Parties".

Evolus, Inc. – Exclusive Distribution and Supply Agreement (January 9th, 2018)

This EXCLUSIVE DISTRIBUTION AND SUPPLY AGREEMENT (this "Agreement") is entered into as of November 30, 2017 (the "Effective Date") by and between EVOLUS, INC. a Delaware Corporation ("EVOLUS"), and CLARION MEDICAL TECHNOLOGIES INC., a body corporate, incorporated under the Ontario Business Corporations Act ("DISTRIBUTOR").

Evolus, Inc. – Exclusive Distribution and Supply Agreement (December 20th, 2017)

This EXCLUSIVE DISTRIBUTION AND SUPPLY AGREEMENT (this "Agreement") is entered into as of November 30, 2017 (the "Effective Date") by and between EVOLUS, INC. a Delaware Corporation ("EVOLUS"), and CLARION MEDICAL TECHNOLOGIES INC., a body corporate, incorporated under the Ontario Business Corporations Act ("DISTRIBUTOR").

Hemispherx BioPharma, Inc. – Sales, Marketing, Distribution, and Supply Agreement {***} (August 29th, 2016)

WHEREAS HEMISPHERX is a biopharmaceutical company with headquarters at One Penn Center, 1617 JFK Boulevard, Suite 500, Philadelphia, PA 19103, U.S. ("HEMISPHERX") and Scientific Products Pharmaceutical Co. LTD is a pharmaceutical company with its primary offices located at Tahlia Street, P.O Box 10485, Riyadh 11433 Saudi Arabia (" SCIEN"), each a "Party" together, "Parties", and

Milestone Scientific – Exclusive Distribution and Supply Agreement (June 30th, 2016)

This Exclusive Distribution and Supply Agreement (this "Agreement") is entered into as of June 20, 2016 by and among Milestone Scientific, Inc. ("Milestone", but solely for the purposes of Section 1.1(b) and Section 13.2), Wand Dental, Inc. ("Supplier") and Henry Schein, Inc. ("HSI").

Hemispherx BioPharma, Inc. – Sales, Marketing, Distribution, and Supply Agreement {***} (May 16th, 2016)

WHEREAS HEMISPHERX is a biopharmaceutical company with headquarters at One Penn Center, 1617 JFK Boulevard, Suite 500, Philadelphia, PA 19103, U.S. ("HEMISPHERX") and Scientific Products Pharmaceutical Co. LTD is a pharmaceutical company with its primary offices located at Tahlia Street, P.O Box 10485, Riyadh 11433 Saudi Arabia (" SCIEN"), each a "Party" together, "Parties", and

Hemispherx BioPharma, Inc. – Sales, Marketing, Distribution, and Supply Agreement (August 12th, 2015)

WHEREAS HEMISPHERX is a biopharmaceutical company with headquarters at One Penn Center, 1617 JFK Boulevard, Suite 500, Philadelphia, PA 19103, U.S. ("HEMISPHERX") and Emerge Health Pty Ltd. is a pharmaceutical company with its primary offices located at Suite 3, Level 1, 2 Theatre Place, Canterbury VIC 3126, Australia (" EMERGE"), each a "Party" together, "Parties" and

Golf Rounds.Com Inc – Distribution and Supply Agreement (August 12th, 2015)

This DISTRIBUTION AND SUPPLY AGREEMENT is made and entered into by and between BIODLOGICS, LLC, a Delaware limited liability company ("BioD"), and Fuse Medical, INC, a Delaware limited liability company ("Distributor"), dated this 8th day of January, 2015 (the "Effective Date"). BioD and Distributor may be referred to herein as a "Party" or, collectively, as the "Parties."

Distribution and Supply Agreement (June 1st, 2015)

This Distribution and Supply Agreement dated as of January 29, 2015 ("Effective Date") is entered into between QBD (QS-IP) LIMITED, a corporation incorporated under the laws of Jersey, Channel Islands, with registered number 109469, and with its registered office at PO Box 1075, Elizabeth House, 9 Castle Street, Jersey, JE4 2PQ, Channel Islands, ("Quotient"), Quotient Suisse SA, a corporation incorporated under the laws of Switzerland, with registered number CHE-167.592.818, and with its registered office at Route de Crassier 13, Business Park Terre Bonne, Batiment B 1, 1262 Eysins, Switzerland, ("Suisse SA"), and Ortho-Clinical Diagnostics, Inc., a corporation incorporated under the laws of New York, and with its principal place of business at 1001 US Highway Route 202, Raritan, New Jersey 08869 ("OCD"). Quotient, Suisse SA and OCD are referred to individually as a "Party" and collectively as the "Parties".

Can-Fite BioPharma Ltd. – Can-Fite Biopharma Ltd and Cipher Pharmaceuticals Inc. Distribution and Supply Agreement Dated as of March 20, 2015 (March 27th, 2015)

12.2 Dispute Resolution 42 12.3 Entire Agreement; Amendments 43 12.4 Tax Withholding 43 12.5 Notices 43 12.6 Assignment 44 12.7 Public Announcements 45 12.8 Severance 45 12.9 Non-Waiver 45 12.10 Further Assurances 45 12.11 Force Majeure 45 12.12 Anti-Corruption 46 12.13 Disclaimer of Agency 46 12.14 Construction 46 12.15 Counterparts 47 12.16 Consents in Writing 47

Hemispherx BioPharma, Inc. – Sales, Marketing, Distribution, and Supply Agreement (March 19th, 2015)

WHEREAS HEMISPHERX is a biopharmaceutical company with headquarters at One Penn Center, 1617 JFK Boulevard, Suite 500, Philadelphia, PA 19103, U.S. ("HEMISPHERX") and Emerge Health Pty Ltd. is a pharmaceutical company with its primary offices located at Suite 3, Level 1, 2 Theatre Place, Canterbury VIC 3126, Australia (" EMERGE"), each a "Party" together, "Parties" and

Klox Technologies, Inc. – Distribution and Supply Agreement Between Klox Technologies Inc. And Sandoz Canada Inc. November 15, 2013 (February 11th, 2015)

This Distribution and Supply Agreement is entered into at the City of Montreal, Province of Quebec, on this 15th day of November, 2013 (the Effective Date) by and between:

Klox Technologies, Inc. – Distribution and Supply Agreement Between Klox Technologies Inc. And Sandoz Canada Inc. November 15, 2013 (January 12th, 2015)

This Distribution and Supply Agreement is entered into at the City of Montreal, Province of Quebec, on this 15th day of November, 2013 (the Effective Date) by and between:

Fuel Distribution and Supply Agreement (October 16th, 2014)

This Fuel Distribution and Supply Agreement (this Agreement) is dated as of October 15, 2014 (the Effective Date), and is made and entered into by and between Western Refining Wholesale, LLC, a Delaware limited liability company (Seller), and Western Refining Southwest, Inc., an Arizona corporation (WRSW and, collectively with all of its divisions, subsidiaries or affiliates, other than the Partnership (as defined below) and its subsidiaries, Purchaser). Seller and Purchaser are individually referred to as a Party and collectively as the Parties.

Western Refining Logistics, LP – Fuel Distribution and Supply Agreement (October 16th, 2014)

This Fuel Distribution and Supply Agreement (this Agreement) is dated as of October 15, 2014 (the Effective Date), and is made and entered into by and between Western Refining Wholesale, LLC, a Delaware limited liability company (Seller), and Western Refining Southwest, Inc., an Arizona corporation (WRSW and, collectively with all of its divisions, subsidiaries or affiliates, other than the Partnership (as defined below) and its subsidiaries, Purchaser). Seller and Purchaser are individually referred to as a Party and collectively as the Parties.

Auxilium Pharmaceuticals, Inc. – DISTRIBUTION AND SUPPLY AGREEMENT by and Between Auxilium Pharmaceuticals, Inc. And Prasco, LLC Dated April 1, 2014 (August 7th, 2014)

This Distribution and Supply Agreement (this Agreement) is made as of April 1, 2014 (the Effective Date), by and between Auxilium Pharmaceuticals, Inc., a Delaware corporation (hereinafter referred to as Manufacturer), and Prasco, LLC, an Ohio limited liability company (hereinafter referred to as Distributor).

Parnell Pharmaceuticals Holdings Pty Ltd – Distribution and Supply Agreement (June 10th, 2014)

This is Amendment number 1 to the agreement between Eli Lilly and Company and Parnell Europe Pty Ltd. titled Distribution and Supply Agreement and dated February 9, 2011 ("Agreement"). By this amendment, entered into on this 2nd day of December, 2011, both parties agree as follows:

Parnell Pharmaceuticals Holdings Pty Ltd – Distribution and Supply Agreement Parnell North America Pty Ltd (June 10th, 2014)

CONFIDENTIAL TREATMENT HAS BEEN REQUESTED AS TO CERTAIN PORTIONS OF THIS DOCUMENT. EACH SUCH PORTION, WHICH HAS BEEN OMITTED HEREIN AND REPLACED WITH AN ASTERISK ***, HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Parnell Pharmaceuticals Holdings Pty Ltd – DISTRIBUTION AND SUPPLY AGREEMENT PARNELL EUROPE PTY LTD ABN A2 138 251 56A and ELANCO, a Division of ELI LILLY and COMPANY (June 10th, 2014)

CONFIDENTIAL TREATMENT HAS BEEN REQUESTED AS TO CERTAIN PORTIONS OF THIS DOCUMENT. EACH SUCH PORTION, WHICH HAS BEEN OMITTED HEREIN AND REPLACED WITH AN ASTERISK ***, HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Parnell Pharmaceuticals Holdings Pty Ltd – Distribution and Supply Agreement (May 1st, 2014)

This is Amendment number 1 to the agreement between Eli Lilly and Company and Parnell Europe Pty Ltd. titled Distribution and Supply Agreement and dated February 9, 2011 ("Agreement"). By this amendment, entered into on this 2nd day of December, 2011, both parties agree as follows:

Parnell Pharmaceuticals Holdings Pty Ltd – Distribution and Supply Agreement (May 1st, 2014)

PARNELL EUROPE PTY LTD ABN 42 138 251 564 a company, organised under the laws of Australia, with registered office at Unit 4, 476 Gardeners Road, Alexandria, New South Wales, Australia Represented by Mr. R JOSEPH, Chief Executive Officer, Hereinafter referred to as Parnell.

Parnell Pharmaceuticals Holdings Pty Ltd – Distribution and Supply Agreement Parnell North America Pty Ltd (May 1st, 2014)